Physician profile
Edward C Elder
NPI 1821039843
$2,688.02
in general payments reported to CMS, 2019-2025
12 companies · $667 in 2025
The $667 reported for 2025 was more than what 84% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $829 · 2020: $286 · 2021: $179 · 2022: $123 · 2023: $182 · 2024: $422 · 2025: $667.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,271.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,271.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $502.70 | 2019-2023 | Total30 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $469.92 | 2019-2021 | |
| Glaukos Corporation | $343.27 | 2019-2025 | Photrexa Viscous and Photrexa, Ce-Marked Kxla System |
| Coopervision INC. | $260.21 | 2025 | Clariti Contact Lens, Myday Contact Lens |
| Biotissue Holdings INC. | $230.12 | 2020-2024 | |
| Bausch & Lomb Americas INC. | $216.25 | 2022-2024 | Infuse, Biotrue One Day, Xiidra |
| Abb Con-Cise Optical Group LLC | $164.52 | 2019 | |
| Lkc Technologies, INC. | $132.24 | 2025 | |
| Amgen INC. | $124.99 | 2024 | Tepezza |
| Johnson & Johnson Vision Care, INC. | $124.98 | 2025 | |
| Optovue, INC. | $87.03 | 2019 | |
| Sight Sciences, INC. | $31.79 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Elder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.